# ALEXANDRIA Study Egypt

> **NCT03583463** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 436 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03583463
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-29
- **Primary completion:** 2021-01-24
- **Final completion:** 2021-01-24
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2022-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03583463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03583463, "ALEXANDRIA Study Egypt". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03583463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*